ALVR logo

AlloVir (ALVR) Operating Profit

Annual Operating Profit

-$181.33 M
-$10.13 M-5.92%

31 December 2023

ALVR Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

-$5.64 M
+$1.63 M+22.38%

30 September 2024

ALVR Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$79.57 M
+$41.32 M+34.18%

30 September 2024

ALVR TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALVR Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.9%+88.0%+55.3%
3 y3 years-154.3%+87.6%+42.9%
5 y5 years-4942.6%+33.5%-362.7%

ALVR Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-154.3%at lowat high+89.9%at high+57.9%
5 y5 years-4942.6%at lowat high+89.9%-362.7%+57.9%
alltimeall time-4942.6%at low-103.3%+89.9%-2769.5%+57.9%

AlloVir Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$5.64 M(-22.4%)
-$79.57 M(-34.2%)
June 2024
-
-$7.26 M(-68.2%)
-$120.89 M(-24.9%)
Mar 2024
-
-$22.84 M(-47.9%)
-$160.94 M(-11.2%)
Dec 2023
-$181.33 M(+5.9%)
-$43.84 M(-6.7%)
-$181.33 M(+1.9%)
Sept 2023
-
-$46.96 M(-0.7%)
-$177.93 M(+2.3%)
June 2023
-
-$47.30 M(+9.4%)
-$173.92 M(+1.6%)
Mar 2023
-
-$43.23 M(+6.9%)
-$171.24 M(+0.0%)
Dec 2022
-$171.20 M(+0.8%)
-$40.43 M(-5.9%)
-$171.20 M(-8.2%)
Sept 2022
-
-$42.95 M(-3.8%)
-$186.56 M(-1.4%)
June 2022
-
-$44.62 M(+3.3%)
-$189.12 M(+3.8%)
Mar 2022
-
-$43.19 M(-22.6%)
-$182.15 M(+7.3%)
Dec 2021
-$169.82 M
-$55.80 M(+22.6%)
-$169.82 M(+21.8%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$45.50 M(+20.8%)
-$139.44 M(+18.3%)
June 2021
-
-$37.66 M(+22.0%)
-$117.83 M(+27.6%)
Mar 2021
-
-$30.86 M(+21.4%)
-$92.33 M(+29.5%)
Dec 2020
-$71.31 M(+167.1%)
-$25.42 M(+6.3%)
-$71.31 M(+28.7%)
Sept 2020
-
-$23.90 M(+96.7%)
-$55.40 M(+38.6%)
June 2020
-
-$12.15 M(+23.5%)
-$39.98 M(+18.4%)
Mar 2020
-
-$9.84 M(+3.5%)
-$33.77 M(+26.5%)
Dec 2019
-$26.70 M(+642.5%)
-$9.51 M(+12.1%)
-$26.70 M(+55.3%)
Sept 2019
-
-$8.48 M(+42.6%)
-$17.20 M(+97.2%)
June 2019
-
-$5.95 M(+114.4%)
-$8.72 M(+214.4%)
Mar 2019
-
-$2.77 M
-$2.77 M
Dec 2018
-$3.60 M
-
-

FAQ

  • What is AlloVir annual operaing income?
  • What is the all time high annual operating profit for AlloVir?
  • What is AlloVir annual operating profit year-on-year change?
  • What is AlloVir quarterly operating income?
  • What is the all time high quarterly operating profit for AlloVir?
  • What is AlloVir quarterly operating profit year-on-year change?
  • What is AlloVir TTM operating income?
  • What is the all time high TTM operating profit for AlloVir?
  • What is AlloVir TTM operating profit year-on-year change?

What is AlloVir annual operaing income?

The current annual operating profit of ALVR is -$181.33 M

What is the all time high annual operating profit for AlloVir?

AlloVir all-time high annual operaing income is -$3.60 M

What is AlloVir annual operating profit year-on-year change?

Over the past year, ALVR annual operaing income has changed by -$10.13 M (-5.92%)

What is AlloVir quarterly operating income?

The current quarterly operating profit of ALVR is -$5.64 M

What is the all time high quarterly operating profit for AlloVir?

AlloVir all-time high quarterly operating income is -$2.77 M

What is AlloVir quarterly operating profit year-on-year change?

Over the past year, ALVR quarterly operating income has changed by +$41.32 M (+88.00%)

What is AlloVir TTM operating income?

The current TTM operating profit of ALVR is -$79.57 M

What is the all time high TTM operating profit for AlloVir?

AlloVir all-time high TTM operating income is -$2.77 M

What is AlloVir TTM operating profit year-on-year change?

Over the past year, ALVR TTM operating income has changed by +$98.36 M (+55.28%)